$88.65
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Country

US

CEO

Mr. Robert Ford

IPO date

1937

Employees

115,000

ISIN

US0028241000

Key stats

Open

$89.20

Volume

13.79M

Market cap

$153.59B

Prev. close

$88.18

Impl / hst vl

-

Open interest

$0.00

$87.73

Day’s Range

$89.20

$81.97

52W Range

$129.46

Valuation

38
Valuation score
Overvalued
P/E
28.43
P/S
3.95
P/B
3.43
Current ratio
1.39
Debt / Equity
0.52
ROE
12.20%
Gross margin
56.29%
Income growth
-39.36%
FCF growth
-65.12

May

15

Dividends

The last payment date was May 15, 2026

Div. per Share

$0.63

Div. Yield

0.71%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 14 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$120.77
The top 28 analysts forecasts that 12-month price may increase by 36.23%, with a low of $92.92 and a high of $142.80
$92.92
Low
$120.77
Avg
$142.80
High
Current price

Earnings

Q1 ‘26 revenue
$11.16B
Q1 ‘26 net income
$1.08B
Revenue
Net income
Previous EPS
$1.50
Estimate EPS
$1.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply